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BACKGROUND: Certain studies suggest that alcohol may reduce the risk of thyroid cancer in women, but the effect in men remains
unclear.
METHODS: We analysed the association between alcohol and thyroid cancer in a large (n¼490159) prospective NIH-AARP Diet and
Health Study with self-reported beer, wine, and liquor intakes.
RESULTS: Over 7.5 years of follow-up (median), 170 men and 200 women developed thyroid cancer. Overall, the thyroid cancer risk
decreased with greater alcohol consumption (X2 drinks per day vs none, relative risk¼0.57, 95% CI 0.36–0.89, P-trend¼0.01).
CONCLUSIONS: These results suggest a potential protective role for alcohol consumption in thyroid cancer.
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The rapid increase in thyroid cancer incidence in the United States
over the past three decades may be related to changes in certain
environmental exposures, as well as increased surveillance and
more widespread use of sensitive diagnostic tools (Enewold et al,
2009). However, despite many retrospective studies, few risk
factors have been established other than childhood exposure to
ionizing radiation (Dal Maso et al, 2009).
Certain studies have suggested an inverse association between
alcohol and thyroid cancer risk, but this may be confounded by
cigarette smoking, which is correlated with alcohol consumption
and has been inversely related with thyroid cancer (Mack et al,
2003; Jee et al, 2004; Nagano et al, 2007). However, no association
was observed in a pooled analysis of 14 case–control studies after
adjusting for smoking (Mack et al, 2003), or in two prospective
studies with fewer than 200 cases (Iribarren et al, 2001; Navarro
Silvera et al, 2005), although these studies were consistent with a
small reduction in risk. A larger prospective study in women (421
cases) showed a clear reduction in risk with greater alcohol
consumption (Allen et al, 2009). Although it remains unclear
whether an association between alcohol and thyroid cancer exists
independently of smoking, there is also a need to investigate effect
modification by sex, given the three-fold higher incidence of
thyroid cancer in women compared with men (Jemal et al, 2008).
Given the evidence of a possible association and a recent
decrease in alcohol consumption in the United States (Zhang et al,
2008; Kerr et al, 2009), we analysed the association between alcohol
intake and the risk of thyroid cancer and its sub-types in a large US
prospective study of over 490000 participants, including more
than 292000 men.
MATERIALS AND METHODS
The NIH-AARP Diet and Health Study began in 1995–1996 when a
questionnaire was mailed to AARP members, aged 50–71 years,
residing in six US states (California, Florida, Louisiana, New
Jersey, North Carolina, and Pennsylvania) and two metropolitan
areas (Atlanta and Detroit; Schatzkin et al, 2001). Participant
mailings and annual linkage to 11 state cancer registries and the
National Death Index provide information on cancer and mortality
outcomes. The NIH-AARP Study was approved by the special
studies institutional review board of the US National Cancer
Institute. Further details on this cohort have been previously
described (Schatzkin et al, 2001).
Among 567169 questionnaire respondents, we excluded in-
dividuals who provided duplicate questionnaires (n¼179), with-
drew from the study (n¼6), moved outside the study area or died
before follow-up (n¼617), were proxy respondents (n¼15760),
had prevalent cancer except non-melanoma skin cancer
(n¼51193) or end-stage renal disease at baseline (n¼997), had
cancer identified only from death records (n¼3876), or had
missing or extreme (greater than twice the interquartile range of
sex-specific transformed intake above the 75th or below the 25th
percentile) caloric intake (n¼4382). The analytic cohort included
490159 participants (292101 men and 198058 women).
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malignant neoplasm diagnosed during follow-up, and
classified histology according to International Classification of
Diseases for Oncology, Third Edition codes (C739) (Fritz et al,
2000).
The self-administered baseline questionnaire inquired about
health-related behaviours, demographics, and anthropometric
characteristics. A supplementary food frequency questionnaire
elicited information on regular dietary habits over the past year,
including serving sizes and frequency of intake of beer
during the summer and rest of the year, wine, and liquor. On
the basis of this information, alcohol consumption was standar-
dised according to the MyPyramid Servings database of the US
Department of Agriculture. One serving (drink) corresponds to 12
fluid ounces of beer (12.96g ethanol), 5 fluid ounces of wine
(13.72g ethanol), and 1.5 fluid ounces of 80-proof distilled spirits
(13.93g ethanol).
Cox proportional hazards models with attained age as the time
metric were used to estimate relative risks (RR) and 95%
confidence intervals (CI) for thyroid cancer in all participants
and by sex. Models were additionally adjusted for sex, race,
smoking status, body mass index (BMI), and family history of
cancer. We mutually adjusted for beer, wine, and liquor in
models of alcohol type. Medians of each exposure category
were modeled as continuous in trend tests. Sub-group
analyses were conducted using categories of sex, smoking status,
BMI, and thyroid cancer histology. The heterogeneity within sub-
groups was assessed using the Q statistic (Cochran, 1954). We
found no evidence that the proportional hazards assumption was
violated.
RESULTS
The median alcohol intake among participants reporting any
alcohol consumption over the past year was 4.5g per day, or
approximately one-third of the amount of a standard alcoholic
drink. Over 11% of the cohort (9574 women and 45149 men)
reported consuming two or more alcoholic drinks daily. There
were higher proportions of beer or liquor drinkers among the
heavier drinking groups, and of wine drinkers among the more
moderate drinking group. Compared with non-drinkers, heavier
drinkers were more likely to be male, white non-Hispanic, more
educated, and to have ever smoked, and less likely to be obese
(Table 1).
Over a median 7.5 years of follow-up, 200 women and 170 men
were diagnosed with thyroid cancer. Compared with non-drinking,
consuming two or more drinks per day was associated with a
significantly decreased risk (RR¼0.57, 95% CI 0.36–0.89, P-
trend¼0.01; Table 2). Consuming one or more drinks per day of
beer was associated with a decreased risk when compared with no
beer drinking, particularly in men (RR¼0.47, 95% CI 0.22–0.97,
P-trend¼0.03). No clear dose-response associations with wine
were observed, but liquor intake was associated with a non-
significant decreased risk in women.
The strength of the inverse association with alcohol intake was
relatively consistent according to sex, smoking status, and BMI
categories, as well as histology (Figure 1). It was stronger in
participants who never smoked (RR¼0.33, 95% CI 0.16–0.71)
when compared with ever smokers (RR¼0.78, 95% CI 0.51–1.19;
P-heterogeneity¼0.05). Although we observed a clearer inverse
association for papillary (RR¼0.58, 95% CI 0.38–0.88) as
compared with follicular cancer (RR¼0.86, 95% CI 0.41–1.80),
these results were not significantly different (P-hetero-
geneity¼0.36). For every 10g consumed, the RRs for thyroid
cancer were 0.95 (95% CI 0.89–1.01) for men, 0.84 (95% CI 0.71–
1.01) for women, and 0.94 (95% CI 0.88–0.99) for men and women
combined. The results were not materially altered after excluding
the first 2 years of follow-up, when the lightest drinkers were
considered as the referent category, or when models were
additionally adjusted for smoking intensity (data not shown).
DISCUSSION
In this large prospective study, we observed that greater alcohol
intake was associated with a reduced risk of thyroid cancer in both
men and women, independent of cigarette smoking. The inverse
association for beer seemed stronger than for wine or liquor,
particularly among men in this cohort. In women, we observed a
nonsignificant inverse association for liquor intake, but no clear
association for other alcohol types. These differences may reflect
the smaller range of alcohol intake in women, residual confounding
by socioeconomic status or related factors, drinking patterns
(i.e., binge drinking), or differences in measurement error by the
Table 1 Study characteristics by alcohol intake (medians or percentage),
using the NIH-AARP Diet and Health Study (n¼490159)
Alcohol (drinks)
None
o1 per
week
1–6 per
week
1–2 per
day
X2 per
day
Study participants 119172 131726 127340 57198 54723
Alcohol (drinks per day) 0 0.06 0.38 1.34 3.66
Alcohol (g per day) 0 0.79 5.16 17.91 50.84
Drinking pattern (%)
Mostly beer drinkers
w N / A 2 02 72 33 3
Mostly wine drinkers
w N / A 4 23 63 61 8
Mostly liquor drinkers
w N / A 2 82 43 64 6
Mixed N/A 10 13 5 4
Age at entry 63.0 62.4 62.1 63.1 62.6
Sex (%)
W o m e n 4 9 5 43 42 81 8
M e n 5 1 4 66 77 28 3
Race/ethnicity (%)
White, non-Hispanic 87 91 93 95 95
Black, non-Hispanic 6 4322
Other 4 4332
Missing 2 1111
Education (%)
Less than high school 35 28 20 18 20
High school graduate 10 11 9 9 9
Some college 22 24 24 23 24
College graduate 29 35 44 49 45
Missing 4 3322
Body mass index (%)
o25kgm
 2 32 34 36 40 34
25–29.9kgm
 2 39 39 44 44 46
X30kgm
 2 26 24 18 15 18
Missing 3 2222
Cigarette smoking status (%)
Never 43 41 33 26 18
Former 42 44 53 58 60
Current 11 12 10 12 19
Missing 4 4444
Family history of cancer (%)
No 46 46 46 46 47
Yes 48 49 49 49 48
Missing 6 5555
wGram intake of specific alcohol type accounts for 750% of total alcohol intake.
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with total alcohol intake were observed by sex, and associations by
alcohol type were generally in the same inverse direction. Although
we observed a clearer reduction in risk for papillary vs follicular
cancers, this difference was not significant. However, there were
only 64 follicular cancers in this study.
Given the strong, positive correlation between alcohol and
smoking, and the evidence linking smoking with a reduced risk of
thyroid cancer (Mack et al, 2003; Jee et al, 2004; Nagano et al,
2007), residual confounding by smoking may have biased our
results away from the null. However, this seems unlikely as a
stronger inverse association for alcohol was observed for never
when compared with ever cigarette smokers.
In a cross-sectional study using ultrasonography, an inverse
association between alcohol consumption and thyroid enlargement
and nodularity was observed (Knudsen et al, 2001). A positive
association between alcohol consumption and thyroid-stimulating
hormone (TSH) and an inverse association with serum T3 was also
found. Thyroid-stimulating hormone, which is secreted by the
pituitary in response to low thyroid hormone levels in the blood, is
known to increase the proliferation of follicular thyroid cells in
laboratory studies (Williams, 1990), although its effect in humans
is not clearly established. Alcohol may protect the thyroid from
elevated TSH by inhibiting thyroid hormone metabolism
(Knudsen et al, 2001). Greater alcohol intake may lead to vitamin
deficiencies, impaired folate metabolism, oxidative stress, and
DNA damage (Boffetta and Hashibe, 2006); but whether these
directly influence the thyroid is unknown.
This is one of the few prospective studies to examine the relation
between alcohol and thyroid cancer risk. A reasonably large
number of cases allowed for sub-group analyses by sex, BMI,
smoking status, and thyroid cancer sub-types; however, there were
too few cases to obtain stable RRs in the heavier-drinking
categories (X2 drinks per day). Participants reported intake
during the past year, which obviously does not cover cumulative
lifetime drinking, and our results could be attenuated by the
inclusion of recent quitters in the reference category of non-
drinkers. However, excluding the first 2 years of follow-up did not
materially change the results, and a similar inverse dose-response
association was observed when the lightest drinkers were the
referent group.
In this large prospective study, we found a reduction in thyroid
cancer risk in both men and women with a greater consumption
of alcohol. The decrease in risk associated with consuming
10g per day is reasonably consistent between women in this study
and in another large prospective study (16 vs 25% per 10g per day;
Allen et al, 2009). However, the direct public health applications of
these findings are limited, considering the evidence linking
moderate-to-heavy alcohol consumption with increases in several
cancers, among other adverse effects (Boffetta and Hashibe, 2006).
Nonetheless, as thyroid cancer incidence is rising, it is important
to analyse the influence of diet and lifestyle in its aetiology.
Table 2 Association between the level of alcohol intake and thyroid cancer risk, using the NIH-AARP Diet and Health Study, (n¼490159)
Total (n¼490159) Women (n¼198058) Men (n¼292101)
Cases/person-
years RR
a
RR
(95% CI)
b
Cases/person-
years RR
a
RR
(95% CI)
b
Cases/person-
years RR
a
RR
(95% CI)
b
Alcohol (drinks)
None 109/812376 1.00 1.00 (Reference) 71/405668 1.00 1.00 (Reference) 38/406708 1.00 1.00 (Reference)
o1 per week 109/913627 0.88 0.87 (0.66–1.13) 70/503876 0.80 0.81 (0.58–1.14) 39/409751 1.02 0.97 (0.62–1.51)
1–6 per week 96/878488 0.89 0.87 (0.66–1.16) 43/300016 0.83 0.84 (0.57–1.24) 53/578473 0.99 0.90 (0.59–1.38)
1–2 per day 32/393092 0.67 0.67 (0.44–1.00) 16/176983 0.52
c 0.55 (0.31–0.95)
c 20/282064 0.76 0.69 (0.40–1.20)
X2 per day 24/369886 0.57 0.57 (0.36–0.89) — — — 20/303931 0.71 0.64 (0.37–1.12)
P-trend 0.01 0.06 0.08
Beer (drinks)
d,e
None 195/1542426 1.00 1.00 (Reference) 135/896073 1.00 1.00 (Reference) 60/646353 1.00 1.00 (Reference)
o1 per week 128/1111220 1.02 1.02 (0.79–1.32) 56/398773 1.01 1.02 (0.72–1.44) 72/712447 0.99 0.99 (0.66–1.48)
1–6 per week 38/481530 0.79 0.79 (0.53–1.17) 9/91697 0.72
f 0.75 (0.37–1.49)
f 29/408543 0.71 0.72 (0.44–1.21)
X1 per day 9/232293 0.40 0.42 (0.21–0.83) — — — 9/213583 0.43 0.47 (0.22–0.97)
P-trend 0.01 0.40 0.03
Wine (drinks)
e,g
None 147/1317699 1.00 1.00 (Reference) 82/549427 1.00 1.00 (Reference) 65/768272 1.00 1.00 (Reference)
o1 per week 145/1267510 1.07 1.05 (0.81–1.37) 80/556231 1.09 1.10 (0.77–1.55) 65/711279 1.05 0.99 (0.67–1.48)
1–6 per week 61/556399 1.11 1.09 (0.77–1.54) 30/204015 1.16 1.15 (0.71–1.86) 31/352384 1.08 1.00 (0.61–1.63)
X1 per day 17/225863 0.77 0.76 (0.45–1.29) 8/76870 0.81 0.83 (0.39–1.77) 9/148993 0.73 0.69 (0.33–1.43)
P-trend 0.69 0.62 0.33
Liquor (drinks)
e,h
None 187/1575603 1.00 1.00 (Reference) 117/725512 1.00 1.00 (Reference) 70/850091 1.00 1.00 (Reference)
o1 per week 124/1145879 0.93 0.93 (0.71–1.20) 63/493054 0.78 0.79 (0.56–1.11) 61/652825 1.20 1.15 (0.77–1.72)
1–6 per week 27/332326 0.79 0.79 (0.51–1.22) 12/92127 0.79 0.82 (0.44–1.54) 15/240199 0.87 0.81(0.44–1.50)
X1 per day 32/313660 1.02 1.02 (0.68–1.53) 8/75849 0.65 0.70 (0.33–1.47) 24/237811 1.40 1.25 (0.74–2.11)
P-trend 0.80 0.46 0.52
aAdjusted for age and sex.
bAdjusted for age, sex, race (non-Hispanic white, non-Hispanic black, other, or missing), education (less than high school, high school graduate, some
college, college graduate, or missing), smoking status (never, former, current, or missing), body mass index (BMI o25, 25–29.9, X30kg m
 2, or missing), and family history of
cancer (no, yes, or missing).
cRelative risks for X1 drink per day vs none.
dOne standardized drink of beer is equal to 12.96g of alcohol.
eBeer, wine, and liquor were mutually
adjusted for in age- and sex-adjusted and multivariable-adjusted models.
fRelative risks for X1 drinks per week vs none.
gOne standardized drink of wine is equal to 13.72g of
alcohol.
hOne standardized drink of liquor is equal to 13.93g of alcohol.
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